An alliance of advocacy groups called The Partnership rallies Congress for funding while rejecting most Trump administration policies impacting the HIV community.
Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.
Drug pricing expert Tim Horn helps us make sense of the administration's future plans for the Medicare Part D and 340B programs.
"While Kavanaugh's appointment to the Supreme Court might not spell the end of the Affordable Care Act it could certainly lead to the chipping away at protections for millions of Americans who benefit from it."
The Trump administration is planning a radical reorganization of the federal government that could adversely impact people living with HIV.
President Trump's budget is viewed as "dead on arrival" by members of Congress, notes Drew Gibson. But don't be fooled, he says: Killer HIV funding threats are not going away -- and here's what you need to do about it.
Trump wants to slash funding for the wildly successful and bipartisan-backed President's Emergency Plan for AIDS Relief (PEPFAR) by $300 million and "begin slowing the rate of new patients on treatment in FY 17."